Skip to content
10-K

Annual Report

PetLife Pharmaceuticals, Inc.

0001493152-17-014624

← back to feed
Filed
Dec 15, 2017 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2017 · Dec 14, 2017 73.97M sh
Operating Cash Flow FY 2017 · Aug 31, 2017 −$318.92K
Operating Cash Flow FY 2017 · Aug 31, 2016 −$151.84K
Cash And Equivalents FY 2017 · Aug 31, 2017 $54.25K
Cash And Equivalents FY 2017 · Aug 31, 2016 $1.17K
Stockholders Equity FY 2017 · Aug 31, 2017 −$1.38M
Stockholders Equity FY 2017 · Aug 31, 2016 −$3.23M
Stockholders Equity FY 2017 · Jun 30, 2015 −$365.13K
Current Liabilities FY 2017 · Aug 31, 2017 $1.44M
Current Liabilities FY 2017 · Aug 31, 2016 $3.24M
Total Liabilities FY 2017 · Aug 31, 2017 $1.44M
Total Liabilities FY 2017 · Aug 31, 2016 $3.24M
Current Assets FY 2017 · Aug 31, 2017 $55K
Current Assets FY 2017 · Aug 31, 2016 $1.17K
Total Assets FY 2017 · Aug 31, 2017 $55K
Total Assets FY 2017 · Aug 31, 2016 $1.17K
Net Income FY 2017 · Aug 31, 2017 −$23.26M
Net Income FY 2017 · Aug 31, 2016 −$3.69M
Net Income FY 2017 · Aug 31, 2016 −$3.69M
Operating Income FY 2017 · Aug 31, 2017 −$22.66M
Operating Income FY 2017 · Aug 31, 2016 −$3.69M